Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
06-05 | Collective bargaining partners in the chemical industry adjourn again | DP |
05-31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
Sales 2024 * | 6.14B 6.59B 5.92B 517B | Sales 2025 * | 6.6B 7.09B 6.37B 557B | Capitalization | 4.88B 5.24B 4.7B 411B |
---|---|---|---|---|---|
Net income 2024 * | 225M 242M 217M 18.97B | Net income 2025 * | 413M 444M 398M 34.82B | EV / Sales 2024 * | 0.84 x |
Net Debt 2024 * | 251M 270M 242M 21.19B | Net Debt 2025 * | 197M 212M 190M 16.61B | EV / Sales 2025 * | 0.77 x |
P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
12.2
x | Employees | - |
Yield 2024 * |
2.51% | Yield 2025 * |
4.14% | Free-Float | 31.67% |
Latest transcript on Wacker Chemie AG
Managers | Title | Age | Since |
---|---|---|---|
Christian Hartel
CEO | Chief Executive Officer | 53 | 31/10/15 |
Jörg Hoffmann
IRC | Investor Relations Contact | - | - |
Thomas Renner
PRN | Corporate Officer/Principal | - | 31/12/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 73 | 07/05/08 | |
Matthias Biebl
BRD | Director/Board Member | 58 | 07/05/08 |
Susanne Weiss
BRD | Director/Board Member | 63 | 07/05/08 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.24% | 19.48B | |
+3.28% | 4.13B | |
+14.93% | 1.54B | |
-4.73% | 1.2B | |
+21.66% | 989M | |
-17.72% | 635M | |
-38.74% | 530M | |
-22.59% | 262M | |
-6.17% | 249M |
- Stock Market
- Equities
- WCH Stock
- WCH Stock